arrow
A

Aaron P. Schultz

Mass General Brigham
H指数:69
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease

身体活动作为临床前期阿尔茨海默病的可改变风险因素

2025-11-030
OAAI
Independent effects of white matter lesion volume and APOE ɛ4 on ARIA-H in A4 Study

A4研究中白质病变体积和APOE ɛ4对ARIA-H的独立影响

2025-10-140
OAAI
Estimating the preclinical Alzheimer's disease course with multimodal data

利用多模态数据估算临床前阿尔茨海默病病程

2025-09-030
OAAI
Latent change-on-change between amyloid accumulation and cognitive decline
2024-10-290
OA
Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease

更大的白质高强度体积与临床前阿尔茨海默氏病的微出血数量有关

2024-08-010
PRE
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration

从横截面淀粉样蛋白,tau和神经变性中识别纵向认知弹性

2024-07-030
OAAI
Amyloid and tau burden relate to longitudinal changes in the performance of complex everyday activities among cognitively unimpaired older adults: results from the performance-based Harvard Automated Phone Task
2024-06-120
OAAI
Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard aging brain study
2024-03-073
PRE
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease

血浆VEGFA和PGF影响临床前阿尔茨海默病的纵向tau和认知

BRAIN
IF11.7
2024-02-056
PRE
Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal AdultsHarvard Aging Brain Study
2023-12-127
PRE
Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease

新奇相关的蓝斑功能与内嗅Tau沉积和临床前阿尔茨海默病记忆减退的关系

2023-09-195
OA
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease
2023-06-084
OAAI